Latest Share Chat

REMOVE ADS

FTSE AIM 100 News

FTSE AIM 100 Information

FTSE AIM 100

FTSE AIM 100 (AIM1) Index Information

Index Value: 3,606.02

Change: 7.71 (0.21%)

Open: 3,605.16

High: 3,619.87

Low: 3,600.69

Yest. Close: 3,598.31006

Last checked at -

REMOVE ADS

Hutchmed enrols last patient in phase 3 lung cancer trial

(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment in its phase three 'Sanovo' trial in China t...

Hutchmed

James Latham revenues rising amid strong timber product demand

(Sharecast News) - James Latham said in an update on Wednesday that revenue rose to £133m in the four months ended 31 July, up from £127m a ...

Latham Timber

LONDON BROKER RATINGS: RBC raises Aberdeen; Exane BNP cuts Fevertree

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

United Utilities + 18 more shares

DIRECTOR DEALINGS: AJ Bell and PetroTal CEOs and Astra CFO sell shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and no...

Astrazeneca + 3 more shares

Redcentric hires former Equipmake, SourceBio finance chief as new CFO

(Alliance News) - Redcentric PLC on Tuesday said it has hired Tony Ratcliffe as chief financial officer and executive director, effective immediately....

Redcentric

LONDON BROKER RATINGS: UBS cuts Legal & General, RBC raises Metro Bank

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Fresnillo + 13 more shares

Redcentric taps Tony Ratcliffe for CFO

(Sharecast News) - IT managed services provider Redcentric said on Tuesday that it has appointed Tony Ratcliffe to take over as chief financial office...

Redcentric

LONDON MARKET CLOSE: FTSE 100 edges up ahead of Trump-Zelensky talks

(Alliance News) - The FTSE 100 made steady progress on Monday ahead of talks between US President Donald Trump, Ukrainian counterpart Volodymyr Zelens...

Babcock + 12 more shares

IN BRIEF: BP Marsh joins US portfolio firm XPT to form Gambit Re

BP Marsh & Partners PLC - London-based private equity investor in early-stage financial services firms - Supports US-based portfolio firm XPT Group LL...

B.p Marsh

Faron secures FDA pathway for lead cancer therapy

(Sharecast News) - Faron Pharmaceuticals said on Monday that it has secured a clear regulatory pathway for the potential approval of its lead cancer t...

Faron Pharmaceuticals

Pantheon appraisal well exceeds pre-drill expectations

(Sharecast News) - Pantheon Resources said on Monday that its Dubhe-1 appraisal well on Alaska's North Slope had exceeded pre-drill expectations in it...

Pantheon Resources plc

Pantheon Resources shares up on better-than-hoped pilot drill result

(Alliance News) - Pantheon Resources PLC on Monday said results from an appraisal well in Alaska exceeded expectations, highlighting the "enormous pot...

Pantheon Resources plc

LONDON BROKER RATINGS: Barclays cuts Segro; RBC cuts Close Brothers

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Segro + 22 more shares

Faron advances development of cancer immunotherapy after FDA feedback

(Alliance News) - Faron Pharmaceuticals Ltd on Monday outlined its plans to further progress its study of an investigational cancer immunotherapy, aft...